Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 79.64 [1][10]. Core Insights - The company's stock repurchase plan, with a total amount of RMB 100-200 million and a maximum repurchase price of RMB 78.0 per share, reflects management's confidence in long-term growth. This repurchase scale and price are at historical highs, indicating a strong belief in future performance [6][7]. - The company is expected to benefit from the release of overseas production capacity and the growth of its proprietary brands, which aligns with industry trends [6][8]. Summary by Sections Financial Performance - Projected revenue for 2024 is RMB 4,465 million, with a growth rate of 19.15%. By 2027, revenue is expected to reach RMB 8,764 million, growing at 25.77% [5]. - The net profit attributable to the parent company is forecasted to be RMB 393.80 million in 2024, increasing to RMB 724.59 million by 2027, reflecting a growth rate of 31.34% [5]. - The earnings per share (EPS) is projected to grow from RMB 1.29 in 2024 to RMB 2.38 in 2027 [5]. Market Position and Trends - The company's proprietary brands, such as "Wang Pi" and "Ling Xian," are experiencing rapid growth, with projected GMV growth rates of 16% and 58% respectively for 2025 [8]. - The introduction of new product lines, such as the "Pong Pong" series, aligns with market trends towards functional and prescription pet food, indicating a strategic response to consumer demands [8]. Production and Capacity - The progress of the second factory in the United States is on track, which, along with the capacity release from factories in Mexico and Canada, is expected to mitigate tariff impacts [9]. - The exchange rate fluctuations are anticipated to have a manageable impact on revenue, with the USD to RMB exchange rate decreasing from 7.12 to 6.99, suggesting a limited effect on earnings [9].